The lower level of CCL2 was also evident in the tissue lysates (Fig. 1D), pleural fluid (Fig. 1E and Fig. S1F), and serum sample (Fig. 1F) of lung adenocarcinoma patients. This evidence concerns the gene CCL2 and lung adenocarcinoma.